Epigenetic inactivation of the NORE1 gene correlates with malignant progression of colorectal tumors
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Chang Kyun | - |
dc.contributor.author | Lee, Jin-Hee | - |
dc.contributor.author | Lee, Min-Goo | - |
dc.contributor.author | Jeong, Seong-In | - |
dc.contributor.author | Ha, Tae-Kyu | - |
dc.contributor.author | Kang, Min-Ju | - |
dc.contributor.author | Ryu, Byung-Kyu | - |
dc.contributor.author | Hwangbo, Young | - |
dc.contributor.author | Shim, Jae-Jun | - |
dc.contributor.author | Jang, Jae Young | - |
dc.contributor.author | Lee, Kil Yeon | - |
dc.contributor.author | Kim, Hyo Jong | - |
dc.contributor.author | Chi, Sung-Gil | - |
dc.date.accessioned | 2021-09-07T23:28:45Z | - |
dc.date.available | 2021-09-07T23:28:45Z | - |
dc.date.created | 2021-06-14 | - |
dc.date.issued | 2010-10-22 | - |
dc.identifier.issn | 1471-2407 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/115497 | - |
dc.description.abstract | Background: NORE1 (RASSF5) is a newly described member of the RASSF family with Ras effector function. NORE1 expression is frequently inactivated by aberrant promoter hypermethylation in many human cancers, suggesting that NORE1 might be a putative tumor suppressor. However, expression and mutation status of NORE1 and its implication in colorectal tumorigenesis has not been evaluated. Methods: Expression, mutation, and methylation status of NORE1A and NORE1B in 10 cancer cell lines and 80 primary tumors were characterized by quantitative PCR, SSCP, and bisulfite DNA sequencing analyses. Effect of NORE1A and NORE1B expression on tumor cell growth was evaluated using cell number counting, flow cytometry, and colony formation assays. Results: Expression of NORE1A and NORE1B transcript was easily detectable in all normal colonic epithelial tissues, but substantially decreased in 7 (70%) and 4 (40%) of 10 cancer cell lines and 31 (38.8%) and 25 (31.3%) of 80 primary carcinoma tissues, respectively. Moreover, 46 (57.6%) and 38 (47.5%) of 80 matched tissue sets exhibited tumor-specific reduction of NORE1A and NORE1B, respectively. Abnormal reduction of NORE1 was more commonly observed in advanced stage and high grade tumors compared to early and low grade tumors. While somatic mutations of the gene were not identified, its expression was re-activated in all low expressor cells after treatment with the demethylating agent 5-aza-dC. Bisulfite DNA sequencing analysis of 31 CpG sites within the promoter region demonstrated that abnormal reduction of NORE1A is tightly associated with promoter CpG sites hypermethylation. Moreover, transient expression and siRNA-mediated knockdown assays revealed that both NORE1A and NORE1B decrease cellular growth and colony forming ability of tumor cells and enhance tumor cell response to apoptotic stress. Conclusion: Our data indicate that epigenetic inactivation of NORE1 due to aberrant promoter hypermethylation is a frequent event in colorectal tumorigenesis and might be implicated in the malignant progression of colorectal tumors. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | BMC | - |
dc.subject | SUPPRESSOR GENE | - |
dc.subject | RAS-EFFECTOR | - |
dc.subject | CPG ISLAND | - |
dc.subject | PROMOTER HYPERMETHYLATION | - |
dc.subject | BREAST CANCERS | - |
dc.subject | RASSF1A | - |
dc.subject | LUNG | - |
dc.subject | ASSOCIATION | - |
dc.subject | METHYLATION | - |
dc.subject | FAMILY | - |
dc.title | Epigenetic inactivation of the NORE1 gene correlates with malignant progression of colorectal tumors | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Chi, Sung-Gil | - |
dc.identifier.doi | 10.1186/1471-2407-10-577 | - |
dc.identifier.scopusid | 2-s2.0-77958028823 | - |
dc.identifier.wosid | 000284040600001 | - |
dc.identifier.bibliographicCitation | BMC CANCER, v.10 | - |
dc.relation.isPartOf | BMC CANCER | - |
dc.citation.title | BMC CANCER | - |
dc.citation.volume | 10 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | SUPPRESSOR GENE | - |
dc.subject.keywordPlus | RAS-EFFECTOR | - |
dc.subject.keywordPlus | CPG ISLAND | - |
dc.subject.keywordPlus | PROMOTER HYPERMETHYLATION | - |
dc.subject.keywordPlus | BREAST CANCERS | - |
dc.subject.keywordPlus | RASSF1A | - |
dc.subject.keywordPlus | LUNG | - |
dc.subject.keywordPlus | ASSOCIATION | - |
dc.subject.keywordPlus | METHYLATION | - |
dc.subject.keywordPlus | FAMILY | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.